Flexible Solutions International Earnings Call Transcripts
Fiscal Year 2025
-
Revenue was flat year-over-year at $38.51M, with net profit down to $787K due to ramp-up costs for new food contracts and Panama factory. Major food contracts are ramping up, with margins expected to improve and profits to rise sharply in the second half of 2026.
-
Q3 2025 revenue rose 13% year-over-year, but one-time ramp-up costs for new food contracts and the Panama plant led to a net loss. EMP division performed strongly, while agriculture sales lagged. Profits are expected to rebound in Q1 2026 as new contracts scale up.
-
Q2 2025 saw 8% sales growth and a net profit of $2.03M, driven by a $2.5M R&D contract. Two major food-grade contracts were secured, with significant revenue expected from Q4 2025. Panama plant will reduce tariff exposure and support international growth.
-
Q1 2025 saw a 19% year-over-year revenue decline and a net loss, mainly due to inventory reductions and upfront costs for new contracts and the Panama factory. Growth is expected in the second half of 2025, with major new food-grade revenue anticipated by early 2026.
Fiscal Year 2024
-
Revenue held steady at $38.23M in 2024, with net profit rising to $3.04M. Major CapEx is planned for a new food-grade contract, and a Panama plant will reduce tariff exposure. Growth is expected in late 2025, driven by new product launches and improved logistics.
-
Q3 2024 saw 7% sales growth and a return to profitability, driven by strong NCS and EMP division performance and operational streamlining. New food and nutraceutical products are nearing commercialization, with potential to double revenue if successful.
-
Q2 2024 saw 2% sales growth and a 59% profit increase, driven by strong food and international sales. The Florida LLC was sold for $2M cash plus $800K/year, with an exclusive supply agreement retained. Growth is expected to continue, especially in food and international markets.